PURPOSE: To test the association between family history of prostate cancer (FH) and prostate cancer (PCa) risk in a large screening program in Brazil, as no conclusive study has yet investigated this. METHODS: Between 2004 and 2007, 17,569 men were screened in 231 small municipalities using mobile screening units. Positive FH was defined as any relative having PCa among screened men. Men were biopsied if they had digital rectal examination suggestive of PCa or PSA >4.0 ng/mL or PSA of 2.5-4 ng/mL with percent free PSA ≤ 15 %. We analyzed the association between FH and PCa using multivariable logistic regression in the first screening round of the program. RESULTS: Positive FH was present in 735 men (4.2 % of total), and they were younger, better educated and more likely to have had previous PCa screening (41.5 vs. 28.5 %; P < 0.001) compared to men with negative FH. FH status did not affect compliance rates in men recommended to undergo biopsy (P = 0.94). In first round, PCa was detected in 3.1 % of screened men (n = 552). In multivariable analysis, positive FH was associated with increased PCa risk (OR = 1.79; 95 % CI, 1.21-2.65; P = 0.003). However, Gleason scores (P = 0.78) or percent of positive cores (P = 0.32) among men with positive biopsies were similar, regardless of FH status. CONCLUSIONS: In Brazil, men with positive FH were at increased PCa risk, which could not be explained by differential biopsy rates. This finding suggests that FH is also a true PCa risk factor in Brazil, a country with highly diverse population in terms of race, ethnicity, culture and socioeconomic status.
PURPOSE: To test the association between family history of prostate cancer (FH) and prostate cancer (PCa) risk in a large screening program in Brazil, as no conclusive study has yet investigated this. METHODS: Between 2004 and 2007, 17,569 men were screened in 231 small municipalities using mobile screening units. Positive FH was defined as any relative having PCa among screened men. Men were biopsied if they had digital rectal examination suggestive of PCa or PSA >4.0 ng/mL or PSA of 2.5-4 ng/mL with percent free PSA ≤ 15 %. We analyzed the association between FH and PCa using multivariable logistic regression in the first screening round of the program. RESULTS: Positive FH was present in 735 men (4.2 % of total), and they were younger, better educated and more likely to have had previous PCa screening (41.5 vs. 28.5 %; P < 0.001) compared to men with negative FH. FH status did not affect compliance rates in men recommended to undergo biopsy (P = 0.94). In first round, PCa was detected in 3.1 % of screened men (n = 552). In multivariable analysis, positive FH was associated with increased PCa risk (OR = 1.79; 95 % CI, 1.21-2.65; P = 0.003). However, Gleason scores (P = 0.78) or percent of positive cores (P = 0.32) among men with positive biopsies were similar, regardless of FH status. CONCLUSIONS: In Brazil, men with positive FH were at increased PCa risk, which could not be explained by differential biopsy rates. This finding suggests that FH is also a true PCa risk factor in Brazil, a country with highly diverse population in terms of race, ethnicity, culture and socioeconomic status.
Authors: M P Staples; G G Giles; D R English; M R E McCredie; G Severi; J S Cui; J L Hopper Journal: Cancer Causes Control Date: 2003-03 Impact factor: 2.506
Authors: Ola Bratt; Hans Garmo; Jan Adolfsson; Anna Bill-Axelson; Lars Holmberg; Mats Lambe; Pär Stattin Journal: J Natl Cancer Inst Date: 2010-08-19 Impact factor: 13.506
Authors: Benjamin A Spencer; Susan H Babey; David A Etzioni; Ninez A Ponce; E Richard Brown; Hongjian Yu; Neetu Chawla; Mark S Litwin Journal: Cancer Date: 2006-02-15 Impact factor: 6.860
Authors: Gerald L Andriole; David L Levin; E David Crawford; Edward P Gelmann; Paul F Pinsky; David Chia; Barnett S Kramer; Douglas Reding; Timothy R Church; Robert L Grubb; Grant Izmirlian; Lawrence R Ragard; Jonathan D Clapp; Philip C Prorok; John K Gohagan Journal: J Natl Cancer Inst Date: 2005-03-16 Impact factor: 13.506
Authors: Edson L Paschoalin; Antonio C P Martins; Mônica Pastorello; Kiyoko A Sândis; Lea M Z Maciel; Wilson A Silva; Marcos A Zago; José Bessa Journal: Int Braz J Urol Date: 2003 Jul-Aug Impact factor: 1.541
Authors: Stijn Roemeling; Monique J Roobol; Stijn H de Vries; Claartje Gosselaar; Theo H van der Kwast; Fritz H Schröder Journal: J Urol Date: 2006-04 Impact factor: 7.450
Authors: Somia Lassed; Cláudia M Deus; Nuno Lourenço; Abderrezak Dahdouh; Albert A Rizvanov; Paulo J Oliveira; Djamila Zama Journal: Biomed Res Int Date: 2016-10-19 Impact factor: 3.411